HER2-positive breast cancer is one of the most aggressive forms of the disease. It tends to grow and spread rapidly. An experimental drug may halt this beast and offer a gentler ride for women living with it .

Cancer researchers are doing more with existing drugs - looking for other applications of some and combining therapies. A combination cocktail seems to work well with HER2-positive breast cancer.

Obesity has been a major topic at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. Excess weight has been shown to be an aggravating factor on a number of fronts. Now, obesity is known to complicate the treatment of HER2-postive breast cancer.

One of the mainstay drugs to treat aggressive breast cancer is very toxic and can cause serious long-term heart problems. A new study has uncovered a treatment regimen that's just effective, but far less toxic.

Herceptin (trastuzumab) has revolutionized the treatment of HER2-positive breast cancer. However, some patients become resistant to the drug. Now, there's new hope for these women.

Aggressive HER-2 positive metastatic breast cancer is difficult to treat. A recent study shows dual medication therapy offers new treatment options - and hope.